SABPA Newsletter May 2010
Table of Contents
SABPA Event
1. The 9th Annual Symposium on Biopharmaceuticals, San Diego Bio-Pharma Conference 2010 (June 5th, 2010) - Online registration closes on June 2
SABPA Event Report
2. The 7th SABPA Entrepreneur Symposium Report (May 15th, 2010)
Community Event
3. The Future of Health Care (June 2nd, 2010)
SABPA Event
1. The 9th Annual Symposium on Biopharmaceuticals, San Diego Bio-Pharma Conference 2010 (June 5th, 2010)
Getting Ahead of the Curve
Date: June 5th, 2010, 8:00am – 4:45pm
Location: Hilton, San Diego/Del Mar
Registration: https://www.123signup.com/event?id=mzgxr $30 for early birds(by May 28), $50 before end of June 2, $80 for onsite registration, students and postdocs $10 off (The fees include parking at the hotel, program brochure, continental breakfast, coffee break, and lunch). Online registration closes on June 2.
Program
8:00 am - 5:00 pm
|
Exhibition
|
8:00 am -8:30 am
|
Continental Breakfast & Registration
|
8:45 am - 9:00 am
|
Welcome
Hui Cai, Ph.D., MBA, Chair of Board, SABPA, Vice President of Business Development, WuXi AppTec
Opening Address
The Honorable Brian P. Bilbray, Member of Congress
|
9:00 am - 10:00 am
|
Session I. Collaborative R&D-Industry and Academia
Session Chair: Peter Zhu, M.S., M.B.A., EVP of SABPA SD, Sr. Scientist, Pfizer
|
|
Diego Miralles, M.D., Head and Chief Medical Officer, J&J PRD West Coast
Xiaodong Wang, Ph.D., Director, National Institute of Biological Sciences, Beijing China
|
10:00 am -10:30 am
|
Coffee Break
|
10:30 pm - 12:00 pm
|
Session II (Plenary Discussion). Emerging Fields and Adapting Strategies
|
|
Lewis Shuster (Moderator), CEO, Shuster Capital
|
|
John Dunn, Executive Vice President, New Ventures, Biogen-Idec
|
|
Greg Heath, Ph.D. Sr. VP & General Manager, Diagnostics Business Unit, Illumina
|
|
Steve Kaldor, Ph.D., President and CEO, Ambrx
|
|
Bob More, M.B.A.,General Partner,Frazier Healthcare Ventures
Richard Neale, Chief Business Officer, Scripps Translational Science Institute
|
12:00 pm - 1:30 pm
|
Luncheon
|
1:30 pm - 2:00 pm
|
San Diego Bio-Pharma Achievement Award
Session Chair: Xiangming Fang, M.D., Ph.D., President of SABPA SD, Sr. VP and CSO, eBioCenter
Award Recipient: Ge Li, Ph.D.Chairman andCEO, WuXi AppTec
|
2:00 pm - 3:00 pm
|
Session III. Drug Discovery in a Global Setting
Session Chair: Mao Mao, Ph.D., Research Fellow, Pfizer
|
|
Steve Yang, Ph.D., Vice President, Head of R&D, Asia at Pfizer
|
|
Troy Wilson, Ph.D., J.D., President and CEO, Intellikine
|
3:00 pm - 3:30 pm
|
Coffee Break
|
3:30 pm - 4:45 pm
|
Session IV (Plenary Discussion). Pharmaceutical Development in China
|
|
John Oyler (Moderator),
|
|
Nancy Chang, Ph.D.,Chairman and Sr. Managing Director, Asia, OrbiMed
James Tong, M.D., Ph.D., CFO, Chief Business & Development Officer, Tianyin Pharmaceutical, China
|
|
Xiaodong Wang, Ph.D., Director, National Institute of Biological Sciences, Beijing China
Steve Yang, Ph.D., Vice President, Head of R&D, Asia at Pfizer
Guo-Liang Yu, Ph.D., President, CEO and Chairman of the Board, Epitomics
|
4:45 pm
|
Closing
|
SABPA Post Event Report
2. The 7th SABPA Entrepreneur Symposium Report (May 15th, 2010)
The 7th SABPA Entrepreneur Symposium was held on May 15, 2010 at the Institute of the Americas, UCSD campus. More than 60 people came to this event on a typically beautiful San Diego Saturday evening. The event speaker Dr. Stephen Flaim, President of the Tech Coast Angels (TCA), presented an informative description of how TCA provide angel funding to startup companies in Southern California, particularly in the San Diego area.
Dr. Flaim first introduced the TCA organization, which was established in 1997. Currently the TCA is the largest angel group in the U.S., with 250 members and 5 networks in various locations in Southern California. Dr. Flaim described in detail TCA’s funding structure and process, including screening, due diligence, term sheet establishment, and final investment. He also summarized the types of companies that TCA is interested in funding. Last but not least, Dr. Flaim provided valuable information about what TCA investors are looking for in startups and what potential deal killers are for investments. Given the current difficult funding climate, Dr. Flaim’s insightful account of how to attract investment is truly appreciated by many people in the audience who are contemplating starting companies.
We would like to thank Dr. Flaim, all attendees and SABPA volunteers for making this event successful. For the presentation slides and for photos showing some memorable moments at the meeting, please visit http://www.sabpa.org/web/news_details.php?ID=245. (By Marie Zhang and Yung-Chih Wang)
Community Event
3. The Future of Health Care (June 2nd, 2010)
When:Wednesday, June 2, 5:30-8:30 pm
Where: AMN Healthcare, 12400 High Bluff Drive, San Diego, California 92130
Speaker: Howard Asher
Join us for this extraordinarily special event as we journey into the future of health care. Howard Asher, a renown storyteller and visionary, will walk us through what we can expect from health care in the not so distant future:
- The Global Healthonomics
- The Role of Information Technology in Health Sciences
- Transforming the Art of Medicine to the Sciences of Health
Howard Asher's career in life sciences began with Pfizer, Baxter and Bayer. In 1978, he founded the first CRO: Advanced Bioresearch Associates, which grew to be the premier Life Science FDA Regulatory Affairs firm; over its 20 years it has secured regulatory approval for hundreds of medical products, including drugs, biotherapeutics, medical devices and in vitro diagnostics.
|
